💨 Abstract
On May 12, 2025, Enanta Pharmaceuticals Inc. (ENTA) reported a fiscal second-quarter loss of $22.6 million, or $1.06 per share, with revenue amounting to $14.9 million. The biotechnology company is based in Watertown, Massachusetts.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
53 Travel Hacks Our Editors Use On Every Trip -
10 Best Growth Stocks to Buy for 2025 -
6 Best ETFs for Weekly Income -
5 Undervalued Blue-Chip Stocks to Buy Right Now -
Falcons sign former Jaguars linebacker Caleb Johnson following tryout at rookie minicamp -
Braves stars Ronald Acuña Jr. and Spencer Strider ramping up their injury rehabs -
Telefonica Brasil: Q1 Earnings Snapshot -
Man accused in Florida State shooting out of hospital and booked into jail on murder charges -
First Guaranty Bancshares: Q1 Earnings Snapshot -
3 die in North Cascades National Park climbing fall -
Powered by MessengerX.io